Impact of pretreatment serum cholinesterase level in unresectable advanced hepatocellular carcinoma patients treated with sorafenib

The value of serum cholinesterase (ChE) level as a predictive marker in sorafenib therapy for advanced hepatocellular carcinoma (HCC) has not yet been investigated. The present retrospective study therefore analyzed the impact of the serum ChE level in 93 patients with advanced HCC treated with sora...

Full description

Saved in:
Bibliographic Details
Main Authors: TAKEDA, HARUHIKO, NISHIKAWA, HIROKI, IGUCHI, ERIKO, OHARA, YOSHIAKI, SAKAMOTO, AZUSA, HATAMARU, KEIICHI, HENMI, SHINICHIRO, SAITO, SUMIO, NASU, AKIHIRO, KOMEKADO, HIDEYUKI, KITA, RYUICHI, KIMURA, TORU, OSAKI, YUKIO
Format: Artigo
Language:Inglês
Published: D.A. Spandidos 2013
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3956264/
https://ncbi.nlm.nih.gov/pubmed/24649154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2012.48
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items